The evolving role of cytoreductive surgery for metastatic renal cell carcinoma.

Oncology (Williston Park, N.Y.)

Volumn 17, Issue 5, 2003, Pages

  Chaudhary, Uzair B ^a   Hull, Gerald W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141834012     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)